(Q70800659)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7241357%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Bioavailability of 11 quinidine formulations adn pharmacokinetic variation in humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7241357%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

Bioavailability of 11 Quinidine Formulations and Pharmacokinetic Variation in Humans (English)

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

29 March 2024

1 reference

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

29 March 2024

1 reference

I. J. McGilveray

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7241357

29 March 2024

K. K. Midha

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7241357

29 March 2024

M. Rowe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7241357

29 March 2024

N. Beaudoin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7241357

29 March 2024

C. Charette

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7241357

29 March 2024

language of work or name

English

0 references

publication date

1 May 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7241357%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 October 2019

https://api.elsevier.com/content/article/PII:S0022354915436986?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

https://api.elsevier.com/content/article/PII:S0022354915436986?httpAccept=text/plain

29 March 2024

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Journal of Pharmaceutical Sciences

29 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7241357%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7241357%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7241357%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

524-529

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7241357%20AND%20SRC:MED&resulttype=core&format=json

Absolute bioavailability of quinidine in two sustained release preparations

14 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Relation between serum quinidine levels and renal function. Studies in normal subjects and patients with congestive failure and renal insufficiency

29 March 2024

4

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Comparative plasma concentrations of quinidine following administration of one intramuscular and three oral formulations to 13 human subjects

29 March 2024

6

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Absolute quinidine bioavailability

29 March 2024

7

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Journal of Pharmacology and Experimental Therapeutics

29 March 2024

8

202

365

Greenblatt

1977

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies

29 March 2024

9

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Comparative Bioavailability of Four Commercial Quinidine Sulfate Tablets

29 March 2024

10

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Correlation of Quinidine Absorption with Disintegration and Dissolution Rates

29 March 2024

11

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

GLC Determination of Quinidine from Plasma and Whole Blood

29 March 2024

16

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

The estimation of quinidine in human plasma by ion pair extraction and high-performance liquid chromatography

29 March 2024

17

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG

29 March 2024

18

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Divergence in pharmacokinetic parameters of quinidine obtained by specific and nonspecific assay methods

29 March 2024

19

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Determination of quinidine and its major metabolites by high-performance liquid chromatography

29 March 2024

21

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

GLC Determination of Quinidines in Human Plasma

29 March 2024

23

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Pharmacokinetic studies of quinidine in patients with arrhythmias

29 March 2024

25

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

High-performance liquid chromatography of quinidine in plasma, with use of a microparticulate silica column

29 March 2024

27

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve

29 March 2024

28

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Single and multiple dose pharmacokinetics of oral quinidine sulfate and gluconate

29 March 2024

29

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Relative Bioavailability of Quinidine Gluconate and Quinidine Sulfate in Healthy Volunteers

29 March 2024

30

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Disposition kinetics of quinidine

29 March 2024

31

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Disposition kinetics of two oral forms of quinidine

29 March 2024

32

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Pharmacokinetics of quinidine related to plasma protein binding in man

29 March 2024

33

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Quinidine kinetics in congestive heart failure

29 March 2024

34

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age

29 March 2024

35

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

Pharmacokinetic and Clinical Implications of Quinidine Protein Binding

29 March 2024

36

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700516

29 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7241357%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference